医薬経済は医療・医薬を取り巻く環境の“いま”にフォーカス!

MENU

RISFAX September 21, 2018

日本語

Impact on the “30 billion yen” market of premier box lunch
Gurunavi: Mostly ordered by pharmaceutical companies, to watch future trends

Consumption tax-linked drug price revision: “October is the only option”
Federation of Pharmaceutical Manufacturers Associations of Japan (FPMAJ): Implementation in April 2018 six months ahead of schedule “incomprehensible”